Molecular mechanisms of drug resistance (2005)

Peer-Reviewed Study · Longley DB, Johnston PG · January 2005

Longley DB et al., 2005-01: Review of drug-resistance mechanisms whose abstract states that resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer. It is a review's summary estimate, not a measured rate.

Resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer

p.275 (Abstract)

Longley DB et al., 2005-01: Review of drug-resistance mechanisms whose abstract states that resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer. It is a review's summary estimate, not a measured rate. No funding or COI captured. This is the origin of the 90% figure as it circulates: note the hedge 'is believed to', and that it measures treatment failure attributed to resistance, not the proportion of patients who develop resistance. No primary dataset is cited in the abstract for the number. The book should quote the hedge, not the round number. Study type: review.